Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1123 of 5804
-
Could a vibrating platform help people with stiff lungs breathe easier?
Disease control CompletedThis randomized controlled trial aims to investigate the clinical and functional effects of Whole Body Vibration (WBV) training when added to a standard pulmonary rehabilitation (PR) program in patients with fibrotic interstitial lung disease (ILD). Participants aged between 40 a…
Phase: NA • Sponsor: Istinye University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New brain zapping method aims to calm shaky hands
Symptom relief Recruiting nowEssential tremor is a common movement disorder that causes involuntary shaking, mainly during voluntary actions such as writing or holding objects. Recent research suggests that essential tremor is not caused by a single brain area, but by abnormal activity within a network that …
Phase: PHASE1, PHASE2 • Sponsor: São Paulo State University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Could a nasal device boost brain health in sleep apnea patients?
Symptom relief Not yet recruitingThis study is a randomized controlled trial with two phases: pre-trial and formal trial. The pre-trial will include 5 participants to observe the 4-week adherence (≥4 hours/night) and safety (adverse event rate) of the iNAP device. For the formal trial, 60 patients with MCI and m…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New heart drug tested in real-world chinese patients
Disease control Recruiting nowThe purpose of this study is to assess the effectiveness of mavacamten treatment in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) in real-world clinical practice
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common heart drug fight staph infections too?
Disease control Recruiting nowThis is an open-label randomized controlled trial which will enroll patients with S. aureus bacteremia who are already taking aspirin for secondary prevention of cardiovascular events. We will randomize patients to continue their aspirin or change clopidogrel which is also approv…
Phase: PHASE4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Brain pacemaker targets cerebellum to quiet severe tremors
Disease control Recruiting nowThis objective of this study is to document the safety and feasibility of electrical stimulation of the deep cerebellar nuclei for refractory tremor using the Medtronic Percept RC Deep Brain Stimulation System. The population will consist of patients that have either failed a pri…
Phase: PHASE1 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a diabetes drug curb cocaine cravings? new trial aims to find out
Disease control Recruiting nowThe purpose of this study is to evaluate semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), in combination with cognitive behavioral therapy (CBT) for the treatment of cocaine use disorder (CUD). This project is part of the NIH Helping to End Addiction Long-term (…
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Ultrasound-Guided Beta-Blockers: a new hope for septic shock?
Disease control Not yet recruitingThe goal of this pilot clinical trial is to determine if conducting a larger study using point-of-care ultrasound (POCUS) to guide beta-blocker therapy in patients with septic shock is feasible. Septic shock is a life-threatening condition where infection causes dangerously low b…
Phase: PHASE1, PHASE2 • Sponsor: John Basmaji • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Magic mushroom compound could help people who stutter
Symptom relief Not yet recruitingThis Phase 2a clinical trial is an open-label, single-group, within-subjects pilot study designed to evaluate the safety, feasibility, and preliminary efficacy of psilocybin as a therapeutic intervention for adults with developmental stuttering. This pilot study will assess wheth…
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New mapping tech could make heart ablation more precise
Disease control Recruiting nowThis pilot study investigates if non-invasive global mapping can guide catheter ablation of atrial fibrillation (AF) by defining personalized targets based on the temporal Stability of local Atrial High-Rate Activity (SAHRA). The study also assesses efficacy and safety of this ap…
Phase: NA • Sponsor: German Heart Institute • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Ketamine may offer new hope for phantom limb pain sufferers
Symptom relief Recruiting nowMust be living Within a 50 mile radius of our study sites: Bay Area, Los Angeles, Albuquerque, Sacramento, Los Angeles An anecdotal report with administration of ketamine in a non-clinical setting providing and sustained remission of symptoms after 6 years has furthered the inte…
Phase: PHASE2, PHASE3 • Sponsor: The Ketamine Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New pill could help ITP patients who failed standard treatments
Disease control Recruiting nowThis is a Phase 2, open-label, randomized, multicenter study to assess the efficacy and safety of DZD8586 in patients with primary immune thrombocytopenia (ITP). The target population of this study is patients with primary ITP who had failed to respond or relapsed after receiving…
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Blood test may end need for risky vein sampling in adrenal hypertension
Diagnosis Not yet recruitingThe goal of this project is to improve the diagnostic pathway for patients with primary aldosteronism, by validating non-invasive biomarkers coupled with routine computed tomography imaging. The aim is to reduce reliance on invasive procedures, shorten diagnostic timelines, and e…
Phase: NA • Sponsor: Changi General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
New combo therapy aims to stop lung cancer's return after surgery
Disease control Recruiting nowThis study will be conducted at Fujian Provincial Cancer Hospital. Its main goals are to evaluate the progression-free survival (PFS) and safety of postoperative immunotherapy combined with radiotherapy in patients with high-risk stage Ⅲ N2 non-small cell lung cancer after surger…
Phase: PHASE4 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New psoriatic arthritis drug shows promise in Mid-Stage trial
Disease control Recruiting nowThe purpose of this study is to evaluate how well the study drug JNJ-88545223 works compared with a placebo (an inactive substance) in adults with active psoriatic arthritis (PsA). The study aims to see whether treatment with JNJ-88545223 can help reduce the signs and symptoms of…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New imaging study aims to stop blindness from misdiagnosed artery inflammation
Knowledge-focused Recruiting nowGiant cell arteritis (GCA) is an inflammation of the blood vessels. A dangerous complication is sudden vision loss due to insufficient blood supply to the optic nerve. However, it is often difficult to distinguish acute vision loss due to GCA from a similar condition of insuffici…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can an immune boost keep myeloma patients Infection-Free on powerful new drugs?
Disease control Recruiting nowMultiple myeloma is a cancer of the plasma cells in the bone marrow. The main aim of this study is to learn how well the Immune Globulin Infusion (human), 10 percentage (%) (IGI, 10%) can help prevent infections in participants with multiple myeloma receiving B-cell maturation a…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Meth treatment study explores whether less use, not just no use, improves health
Disease control Recruiting nowReduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge g…
Phase: NA • Sponsor: William Stoops • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
FitBit and coaching app aim to ease CAR-T side effects in landmark trial
Symptom relief Recruiting nowThe overall purpose of this randomized control trial (RCT) is to determine the clinical effect of a multilevel, RPM-enhanced intervention during and after completion of outpatient CAR-T therapy in 190 patients and their family caregivers (FCGs).
Phase: PHASE3 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New hope for Hard-to-Treat cancers? first human trial launches
Disease control Recruiting nowA Phase I, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AT03-65 in Adults with Advanced Solid Tumors
Phase: PHASE1 • Sponsor: Axcynsis Therapeutics Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC